Cytelife Pharmaceuticals LLP
About Cytelife Pharmaceuticals LLP
Data last updated:
Cytelife Pharmaceuticals LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 19 February 2013 and has been in existence for over 13 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAB-3659. Its GSTIN is 02AAIFC6059M1ZA (Himachal Pradesh). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹27 Lakh. It is led by designated partners Mohammad Hasim Mohammad Daud and Aishah Mohammad Hashim Chaudhary.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Balaji Indus Park L.S.No. 119/2&3 120/1&2 Gala No C – 10 Tondre Village, Thane, Maharashtra, India – 410206.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹1.45 Cr. For the same year it recorded a net profit of ₹57,167 (net margin 0.4%) and EBITDA of ₹98,127 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 23% over five years.
Company details
Contact details
Cytelife Pharmaceuticals LLP's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressBalaji Indus Park L.S.No. 119/2&3 120/1&2 Gala No C – 10 Tondre Village, Thane, Maharashtra, India – 410206
- IndustryBusiness Services, Other Services
To see the full contact details of Cytelife Pharmaceuticals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cytelife Pharmaceuticals LLP
FY 2023 filings availableCytelife Pharmaceuticals LLP reported revenue of ₹1.45 Cr for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | ₹1.45 Cr | ||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹57,167 | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 0.4% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Cytelife Pharmaceuticals LLP, buy the company report.
Designated partners of Cytelife Pharmaceuticals LLP
Cytelife Pharmaceuticals has 2 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Hasim Mohammad Daud | Designated Partner | 19 Feb 2013 | 13 Years 8 Months | Current |
| Aishah Mohammad Hashim Chaudhary Also directs: Cytelife Healthcare Services Private Limited | Designated Partner | 11 Apr 2016 | 10 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Cytelife Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cytelife Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cytelife Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAIFC6059M1ZA | Himachal Pradesh | Active | 01 Mar 2021 |
To see the full GST registrations and return filing status of Cytelife Pharmaceuticals LLP, buy the company report.
Recent activity
Cytelife Pharmaceuticals LLP has 7 designated partner changes on record since 2013: 2 appointments and 5 cessations. The latest: Mohd Ismail Khursheed Ahmad Ansari ceased to be Partner on 18 Jan 2023.
Frequently asked questions
Cytelife Pharmaceuticals is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in other services, within the business services industry. It was incorporated on 19 February 2013 (13+ years old) and is registered under LLPIN AAB-3659.
Cytelife Pharmaceuticals has 2 current designated partners:
- Mohammad Hasim Mohammad Daud - Designated Partner
- Aishah Mohammad Hashim Chaudhary - Designated Partner
The latest financial statements of Cytelife Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Cytelife Pharmaceuticals is 02AAIFC6059M1ZA, registered in Himachal Pradesh. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Cytelife Pharmaceuticals is AAB-3659. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Cytelife Pharmaceuticals was incorporated on 19 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Mohd Ismail Khursheed Ahmad Ansari ceased to be Partner on 18 Jan 2023. Aishah Mohammad Hashim Chaudhary was appointed as Designated Partner on 11 Apr 2016. Ajaz Ahmad ceased to be Partner on 11 Apr 2016. Cytelife Pharmaceuticals has 7 designated partner changes on record in total.
The registered office of Cytelife Pharmaceuticals is at Balaji Indus Park L.S.No. 1192&3 1201&2 Gala No C – 10 Tondre Village, Thane, Maharashtra, India – 410206.
Cytelife Pharmaceuticals operates in the business services industry, in the other services segment.
Cytelife Pharmaceuticals can be reached at its registered office: Balaji Indus Park L.S.No. 1192&3 1201&2 Gala No C – 10 Tondre Village, Thane, Maharashtra, India – 410206.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
